Can your own blood help regrow hair? new trial tests PRP for scarring hair loss
NCT ID NCT06998433
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a scarring hair loss that mostly affects women of African descent. PRP is made from a patient's own blood and is thought to reduce inflammation and promote healing. The trial will compare PRP to a placebo in 56 women, with all participants continuing standard topical steroid treatment. The goal is to see if PRP can stop hair loss and encourage regrowth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Platelet-Rich Plasma (PRP) injections
- What this could lead to
- If it works, this could point toward a new treatment option for central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss that currently has no standard treatment guidelines.
- What could go wrong
- This is a small, early-phase trial with only 56 participants, so results may not apply to everyone. PRP is generally safe but may cause minor discomfort from injections, and there is a small risk of disease progression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jamail Specialty Care Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.